World Summit on Stress, Obesity & Diabetes

Dear Attendees,

Times Scientific Group proudly presents the World Summit on Stress, Obesity & Diabetes , taking place on September 21- 22, 2026, in Berlin, Germany.

This international summit serves as a premier global platform for exploring the latest developments in stress science, metabolic disorders, and diabetes research. The event aims to unite clinicians, researchers, endocrinologists, psychologists, nutritionists, public-health professionals, and industry leaders to foster cross-disciplinary collaboration and promote innovative approaches for prevention, treatment, and patient-centered care.

Participants will gain insights into stress physiology, neuroendocrine regulation, behavioral therapy, metabolic health, obesity pharmacotherapy, and advanced diabetes management, with an emphasis on integrated care and lifestyle-based interventions.

Advancements in Stress, Obesity & Diabetes Research:

•    Stress Science: Advances in neurobiology, digital mental health, and behavioral interventions are transforming stress detection and management. AI-powered monitoring tools and digital therapeutics are helping individuals build resilience and improve psychological well-being.
•    Obesity Management: The development of next-generation anti-obesity drugs such as GLP-1 and dual agonists, coupled with precision nutrition and metabolic profiling, has revolutionized weight management and long-term metabolic control.
•    Diabetes Care: Breakthroughs in continuous glucose monitoring, insulin pumps, and artificial pancreas systems are reshaping diabetes treatment. Pharmacogenomics and digital health solutions are driving personalized and data-driven approaches to diabetes management.

Visa & Travel Assistance
All registered international delegates will receive an official invitation letter to support visa applications. We recommend applying early and using the official invitation for embassies/consulates. Our team will provide travel guidance, local logistics, and accommodation options to simplify planning.

Why Attend?

By joining the World Summit on Stress, Obesity & Diabetes you will:
•    Discover the latest clinical evidence, guidelines, and breakthroughs across behavioral health, obesity therapeutics, and diabetes care.
•    Learn practical strategies to integrate mental-health care into metabolic disease management.
•    Network with clinicians, researchers, public-health officials, pharmaceutical and digital-health innovators.
•    Contribute to collaborative solutions (policy, care pathways, and implementation) that can be applied within health systems worldwide.

Market Analysis - Stress, Obesity & Diabetes (US, Europe & Asia - 2024–2025 snapshots)

Global diabetes therapeutics -The global diabetes drugs market was reported at roughly USD ~88.3 billion in 2024, with strong projected growth into 2025 and beyond driven by new therapies and broader access in major markets. North America accounted for a large share in 2024. 

Obesity/weight-loss market - Spending on obesity therapies (including the recent wave of GLP-1 agents) surged in recent years; global obesity spending was already approaching the tens of billions with forecasts of very rapid growth through the latter half of the decade as new medications scale globally. Industry analyses in 2024–2025 show the obesity market entering an inflection point with multi-year high CAGRs. 

Stress & mental-health tools - The workplace/stress-management and digital mental-health markets are expanding: workplace stress management markets were estimated in the low billions (USD) in 2024 and digital mental-health/therapy apps exceeded several billion USD globally, reflecting rising demand for accessible care and employer-sponsored programs.